Abstract:1887 Purposes: Reduced capacity to repair mutagen-induced DNA damage is implicated in susceptibility to cancer development. The nicotine-derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced lung adenocarcinogen through formation of DNA adducts. Methods: We used the comet assay to assess whether susceptibility to NNK-induced DNA damage was associated with increased risk of lung cancer in a hospital-based case-control study. We measured baseline and NNK-induced DNA damage in peripheral blood lymphocyte assays from 401 previously untreated Caucasian lung cancer cases and 388 matched healthy controls. DNA damage using NNK as the mutagen challenge was visualized with the comet assay and quantified by the Olive tail moment parameter. Multivariable analysis was used to assess risks for lung cancer associated with level of DNA damage. Results: The baseline levels of DNA damage were statistically significantly higher in cases than in controls (tail moments: 1.22±0.57 vs. 1.14±0.50, P =0.025), as were NNK-induced DNA damage (2.42±1.15 vs. 2.16±1.07, P =0.001). The net NNK-induced DNA damage (NNK-induced subtracted by baseline) was also significantly higher in cases compared with controls (1.20 vs. 1.03, P = 0.018). When data were dichotomized at the median value of olive tail moments in the controls and adjusted for age, sex, and smoking status, higher levels of net NNK-induced DNA damage were associated with a significantly increased lung cancer risk (odds ratio [OR] = 1.45, 95% CI = 1.09 to 1.94). In addition, there was also a significant dose effect. Compared to individuals in the lowest quartile of damage, the ORs for individuals in the second, third and fourth quartiles were 1.32 (95% CI: 0.86-2.03), 1.59 (95% CI: 1.04-2.43), and 1.78 (95% CI: 1.17-2.70), respectively (P-for trend =0.005). In stratified analysis, the elevated risk appeared to be higher in adenocarcinoma (OR=1.50, 95% CI: 1.05-2.13) than in other histologies (OR=1.38, 95% CI, 0.95-2.00), and higher in heavy smokers (OR=1.64, 95% CI: 1.09-2.47) than in light smokers (OR=1.49, 95% CI, 0.79-2.79). Conclusions: This is the first study to use NNK as a challenge mutagen in the comet assay. The results suggest that NNK-induced DNA damage is associated with an increased risk of lung adenocarcinoma and the net NNK-induced olive tail moment measure may serve as a useful predictor of lung cancer risk. Supported by NCI grants CA 55769, CA 70907 and CA 86390.

Nicotine Inhibits the Cytotoxicity and Genotoxicity of NNK Mediated by CYP2A13 in BEAS-2B Cells

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Involvement of P53 Mutation and Mismatch Repair Proteins Dysregulation in NNK-Induced Malignant Transformation of Human Bronchial Epithelial Cells

Nicotine Component of Cigarette Smoke Extract (CSE) Decreases the Cytotoxicity of CSE in BEAS-2B Cells Stably Expressing Human Cytochrome P450 2A13

Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and β-adrenergic receptor signaling pathways

Nicotine Enhances Invasion and Metastasis of Human Colorectal Cancer Cells Through the Nicotinic Acetylcholine Receptor Downstream P38 MAPK Signaling Pathway.

Nicotinamide N-methyltransferase Enhances the Capacity of Tumorigenesis Associated with the Promotion of Cell Cycle Progression in Human Colorectal Cancer Cells.

Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines ( N -nitrosonornicotine and N -nitrosoanabasine) in human cells, partially different CYPs being activating enzymes

The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors

Effects of Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on the Activation of ERK1/2 MAP Kinases and the Proliferation of Human Mammary Epithelial Cells.

Genotoxicity Study on Nicotine and Nicotine-Derived Nitrosamine by Accelerator Mass Spectrometry

NNK-induced DNA Damage As Measured by the Comet Assay is a Marker of Lung Cancer Risk

Substantial Reduction in Risk of Lung Adenocarcinoma Associated with Genetic Polymorphism in CYP2A13, the Most Active Cytochrome P450 for the Metabolic Activation of Tobacco-Specific Carcinogen NNK.

4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone Promoted Gastric Cancer Growth Through Prostaglandin E Receptor (EP2 and EP4) in Vivo and in Vitro

Tobacco-specific Carcinogen 4-(Methylnitrosoamino)-1-(3-pyridyl)-1-butanone(nnk) Activating ERK1/2 MAP Kinases and Stimulating Proliferation of Human Mammary Epithelial Cells

Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1

Effects of vitamins and common drugs on reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rat microsomes

[Induction of Pulmonary Precancerous Lesions by Tobacco-Specific NNK in Wistar Rats].

Electric Cell-Substrate Impedance Sensing (ECIS) for Profiling Cytotoxicity of Cigarette Smoke

Nicotine prevents the apoptosis induced by menadione in human lung cancer cells.

Nicotine interacts with DNA lesions induced by alpha radiation which may contribute to erroneous repair in human lung epithelial cells